Related by context. Frequent words. (Click for all words.) 74 Preclinical Data 74 Drug Candidate 73 Clinical Trial Results 73 Phase III Clinical Trial 73 refractory chronic lymphocytic 73 Patient Enrollment 72 Metastatic Melanoma 71 Presents Positive 71 Golimumab 71 Pivotal Study 71 Pivotal Phase III 71 Completes Enrollment 70 Voreloxin 70 Panzem R 70 Pivotal Phase 70 II Clinical Trial 70 forodesine 70 Phase III Trial 69 Chronic Hepatitis C 69 Epratuzumab 69 FDA Accepts 69 R sorafenib tablets 69 Daclizumab 69 Well Tolerated 69 Dapagliflozin 69 liposomal formulation 69 ThermoDox R 69 Single Dose 69 Bortezomib 68 Initiate Phase 68 phenylketonuria PKU developed 68 Cetrorelix 68 Prostate Cancer Patients 68 Coadministration 68 Monotherapy 68 Cethromycin 68 Ofatumumab 68 Kuvan R 68 Bevacizumab 68 Pulmonary Arterial Hypertension 68 Advanced Prostate Cancer 68 Diabetic Macular Edema 67 CCX# 67 Aliskiren 67 PEG SN# 67 Monoclonal Antibody 67 Belimumab 67 Hepatitis C Virus HCV 67 Recombinant Human 67 Small Molecule 67 Lung Cancer Patients 67 Copegus R 67 Solid Tumors 67 Metastatic Colorectal Cancer 67 Elderly Patients 67 Ixempra 67 INCB# [001] 67 MORAb 67 Generic Version 67 multi kinase inhibitor 67 polymerase inhibitor 67 Irinotecan 66 MKC# 66 Combination Therapy 66 Gastric Cancer 66 Allovectin 7 R 66 RGB # 66 RNAi Therapeutics 66 Advancing Drugs 66 Initiates Phase 66 Eltrombopag 66 Pivotal Trial 66 J Am Coll 66 Tesetaxel 66 Develop Novel 66 Offering Pilates 66 KRN# 66 Microplasmin 66 Capecitabine 66 sodium Injection 66 FDA Clears 66 Perifosine 66 Tolerability 66 IMC #B 66 Carfilzomib 66 Denufosol 66 Alemtuzumab 66 Entereg R 66 Talactoferrin 66 DAVANAT 66 Dasatinib 65 Vandetanib 65 Pirfenidone 65 Patients Treated 65 Clofarabine 65 metastatic castration resistant 65 Inc Therapeutic Competitors 65 Newly Diagnosed 65 pertuzumab 65 anticancer compound 65 Icatibant